How do you pay?

How to pay the least

Ask for the cash price

Stelara

Stelara is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Stelara’s cash price, and one or two other pharmacies too.
  2. Stelara’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameStelara
Authorized genericustekinumab
Regular genericustekinumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Stelara?
The original
–
–

Brand nameThe maker’s card

STELARA withMe Savings Program

Savings card from Johnson & Johnson (Janssen)

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $5 a dose

Sign up on asset.jnjwithme.com 

Or call 1-844-494-8463.

In the maker’s words

“Pay as little as $5 per dose…”

From the maker’s offer on asset.jnjwithme.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Stelara itself, from the same company, sold without the brand name, and usually for less. For now Stelara is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Stelara is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

STELARA is a human interleukin-12 and -23 antagonist indicated for the treatment of:

  • Moderate to severe plaque psoriasis in adults and pediatric patients 6 years of age and older who are candidates for phototherapy or systemic therapy.
  • Active psoriatic arthritis in adults and pediatric patients 6 years of age and older.
  • Moderately to severely active Crohn's disease in adults and pediatric patients 2 years of age and older.
  • Moderately to severely active ulcerative colitis in adults and pediatric patients 2 years of age and older.

Source: the FDA label for Stelara (Janssen Biotech, Inc.), September 8, 2026. Full label on DailyMed 

Good to know